FDA Approved: ROBAXIN — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Robaxin (methocarbamol) submitted by Hikma Pharmaceuticals USA Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Muscle Spasm
• Musculoskeletal Disorders
• Musculoskeletal Pain

Drugs mentioned

• ROBAXIN (METHOCARBAMOL)

Snippet

SUPPL AP for ROBAXIN (METHOCARBAMOL)